Eric Hare, BS

AnaptysBio

Poster(s):

• W173 - Rosnilimab, a Novel PD-1 Agonist Monoclonal Antibody, Demonstrated Modulation of Peripheral T Cell Activity and Reduction of Circulating PD-1high Expressing CD4 and CD8 T Cells in a Phase 1 Healthy Volunteer Clinical Trial
  Wednesday, June 22, 2022

  6:15 PM – 7:30 PM PT